Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Return on Invested Capital: 2025

Historic Return on Invested Capital for Keros Therapeutics (KROS) over the last 1 years, with Sep 2025 value amounting to 0.06%.

  • Keros Therapeutics' Return on Invested Capital was N/A to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year change of. This contributed to the annual value of -0.38% for FY2020, which is N/A change from last year.
  • Per Keros Therapeutics' latest filing, its Return on Invested Capital stood at 0.06% for Q3 2025, which was up 20,553.14% from 0.00% recorded in Q2 2025.
  • Over the past 5 years, Keros Therapeutics' Return on Invested Capital peaked at 0.06% during Q3 2025, and registered a low of -0.00% during Q1 2025.
  • In the last 1 years, Keros Therapeutics' Return on Invested Capital had a median value of 0.00% in 2025 and averaged 0.02%.